Artwork

Content provided by Dr. Emma Nichols. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Emma Nichols or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Season 2: 014 - AI for Detecting Fluctuations in Blood Potassium Levels

19:19
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 06, 2018 05:00 (5+ y ago). Last successful fetch was on August 31, 2018 22:29 (5+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 206582417 series 1941234
Content provided by Dr. Emma Nichols. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Emma Nichols or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs. John Dillon and Paul A. Friedman with the Mayo Clinic recently described their strategy for using AI to create a “bloodless blood test”, a new way of detecting fluctuations of blood potassium levels that patients can perform at home without drawing blood. They described the strategies they used for the development of this test in a recent article in the Harvard Business Review. In our interview, I asked them to elaborate further on the development of this test and discuss some of the limitations as well as the implications for other potential biomarker/symptom correlations that may be measurable with similar approaches.

John J. Dillon, MD, is the director of Mayo Clinic Dialysis Services in the Division of Nephrology & Hypertension and is the former director of the Mayo Clinic’s Nephrology Hospital Practice and Paul A. Friedman, MD, is the chair of the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Previously, he served as director of the Mayo Clinic’s Cardiac Implantable Device Lab.

  continue reading

23 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 06, 2018 05:00 (5+ y ago). Last successful fetch was on August 31, 2018 22:29 (5+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 206582417 series 1941234
Content provided by Dr. Emma Nichols. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Emma Nichols or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs. John Dillon and Paul A. Friedman with the Mayo Clinic recently described their strategy for using AI to create a “bloodless blood test”, a new way of detecting fluctuations of blood potassium levels that patients can perform at home without drawing blood. They described the strategies they used for the development of this test in a recent article in the Harvard Business Review. In our interview, I asked them to elaborate further on the development of this test and discuss some of the limitations as well as the implications for other potential biomarker/symptom correlations that may be measurable with similar approaches.

John J. Dillon, MD, is the director of Mayo Clinic Dialysis Services in the Division of Nephrology & Hypertension and is the former director of the Mayo Clinic’s Nephrology Hospital Practice and Paul A. Friedman, MD, is the chair of the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Previously, he served as director of the Mayo Clinic’s Cardiac Implantable Device Lab.

  continue reading

23 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide